Cargando…

A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis

PURPOSE: Animal models are necessary in understanding the pathogenesis of endophthalmitis and are also necessary to assist the development of new therapeutics for this sight-threatening ocular inflammation. Hamilton syringes are usually preferred to inject pathogens when performing experiments on te...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudraprasad, Dhanwini, Gandhi, Jaishree, Naik, Poonam, N Naik, Milind, Naidu, Chenchu, Kumar Mishra, Dilip, Joseph, Joveeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PUBLISHED BY KNOWLEDGE E 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432928/
https://www.ncbi.nlm.nih.gov/pubmed/37600911
http://dx.doi.org/10.18502/jovr.v18i3.13775
_version_ 1785091535110406144
author Rudraprasad, Dhanwini
Gandhi, Jaishree
Naik, Poonam
N Naik, Milind
Naidu, Chenchu
Kumar Mishra, Dilip
Joseph, Joveeta
author_facet Rudraprasad, Dhanwini
Gandhi, Jaishree
Naik, Poonam
N Naik, Milind
Naidu, Chenchu
Kumar Mishra, Dilip
Joseph, Joveeta
author_sort Rudraprasad, Dhanwini
collection PubMed
description PURPOSE: Animal models are necessary in understanding the pathogenesis of endophthalmitis and are also necessary to assist the development of new therapeutics for this sight-threatening ocular inflammation. Hamilton syringes are usually preferred to inject pathogens when performing experiments on test subjects, however, this method has technical and financial disadvantages. In this study, we report the findings and assess the related benefits of applying a novel low-cost intravitreal injection technique to initiate endophthalmitis in a mouse model while using the Eppendorf tip and a 26G needle. METHODS: The 18-hr culture of clinical isolates of bacteria (Staphylococcus aureus and Pseudomonas aeruginosa) and fungus (Aspergillus flavus and Candida albicans) were resuspended to a final concentration of 10,000 colony forming units (CFU)/1 µL which were separately injected intravitreally into C57BL/6 mice (6–8 weeks) using a 0.1–2.5µL pipette attached to the modified Eppendorf tip with a 26G needle. The contralateral eye served as vehicle/uninjected control. Disease progression was determined by assessing the corneal haze, opacity, bacterial burden, and retinal histology of the eyes used in the model. Following euthanization, bacteria-infected mice were enucleated after 24 hr of the initial injection, and fungus-infected mice after 72 hr. RESULTS: Of the 50 mice injected, the modified technique was successful in 48 mice. Two mice were excluded due to cataract formed by accidental injury to the lens. The experimental endophthalmitis mice model successfully mimicked the natural clinical course. Clinical assessment and histopathology confirmed the influx of inflammatory cells into the posterior segment of the eye along with dissolution of retinal architecture. CONCLUSION: Our novel method of injection using a modified Eppendorf tip and 26G needle yielded a cost-effective mouse model of clinical endophthalmitis, resulting in reproducible infection for understanding various aspects of its pathobiology.
format Online
Article
Text
id pubmed-10432928
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher PUBLISHED BY KNOWLEDGE E
record_format MEDLINE/PubMed
spelling pubmed-104329282023-08-18 A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis Rudraprasad, Dhanwini Gandhi, Jaishree Naik, Poonam N Naik, Milind Naidu, Chenchu Kumar Mishra, Dilip Joseph, Joveeta J Ophthalmic Vis Res Original Article PURPOSE: Animal models are necessary in understanding the pathogenesis of endophthalmitis and are also necessary to assist the development of new therapeutics for this sight-threatening ocular inflammation. Hamilton syringes are usually preferred to inject pathogens when performing experiments on test subjects, however, this method has technical and financial disadvantages. In this study, we report the findings and assess the related benefits of applying a novel low-cost intravitreal injection technique to initiate endophthalmitis in a mouse model while using the Eppendorf tip and a 26G needle. METHODS: The 18-hr culture of clinical isolates of bacteria (Staphylococcus aureus and Pseudomonas aeruginosa) and fungus (Aspergillus flavus and Candida albicans) were resuspended to a final concentration of 10,000 colony forming units (CFU)/1 µL which were separately injected intravitreally into C57BL/6 mice (6–8 weeks) using a 0.1–2.5µL pipette attached to the modified Eppendorf tip with a 26G needle. The contralateral eye served as vehicle/uninjected control. Disease progression was determined by assessing the corneal haze, opacity, bacterial burden, and retinal histology of the eyes used in the model. Following euthanization, bacteria-infected mice were enucleated after 24 hr of the initial injection, and fungus-infected mice after 72 hr. RESULTS: Of the 50 mice injected, the modified technique was successful in 48 mice. Two mice were excluded due to cataract formed by accidental injury to the lens. The experimental endophthalmitis mice model successfully mimicked the natural clinical course. Clinical assessment and histopathology confirmed the influx of inflammatory cells into the posterior segment of the eye along with dissolution of retinal architecture. CONCLUSION: Our novel method of injection using a modified Eppendorf tip and 26G needle yielded a cost-effective mouse model of clinical endophthalmitis, resulting in reproducible infection for understanding various aspects of its pathobiology. PUBLISHED BY KNOWLEDGE E 2023-07-28 /pmc/articles/PMC10432928/ /pubmed/37600911 http://dx.doi.org/10.18502/jovr.v18i3.13775 Text en Copyright © 2023 Rudraprasad et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rudraprasad, Dhanwini
Gandhi, Jaishree
Naik, Poonam
N Naik, Milind
Naidu, Chenchu
Kumar Mishra, Dilip
Joseph, Joveeta
A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis
title A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis
title_full A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis
title_fullStr A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis
title_full_unstemmed A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis
title_short A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis
title_sort novel and low-cost approach for intravitreal injection in an experimental model of endophthalmitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432928/
https://www.ncbi.nlm.nih.gov/pubmed/37600911
http://dx.doi.org/10.18502/jovr.v18i3.13775
work_keys_str_mv AT rudraprasaddhanwini anovelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT gandhijaishree anovelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT naikpoonam anovelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT nnaikmilind anovelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT naiduchenchu anovelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT kumarmishradilip anovelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT josephjoveeta anovelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT rudraprasaddhanwini novelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT gandhijaishree novelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT naikpoonam novelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT nnaikmilind novelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT naiduchenchu novelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT kumarmishradilip novelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis
AT josephjoveeta novelandlowcostapproachforintravitrealinjectioninanexperimentalmodelofendophthalmitis